MissionIR Articles
-
MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Receives FDA Fast Track Designation for CLD-201 in Soft Tissue Sarcoma
Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted genetic medicine delivery therapies, announced that the U.S. Food and Drug Administration granted Fast Track designation to CLD-201 (SuperNova), its allogeneic adipose stem-cell loaded oncolytic virus for treating soft tissue sarcoma. The designation provides opportunities for expedited development, including priority review and accelerated approval.…
-
MissionIRNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Completes Name and Ticker Change from Mullen Automotive
Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced that its previously disclosed name change from Mullen Automotive Inc. to Bollinger Innovations, Inc. is effective as of July 28, 2025, along with its new Nasdaq stock symbol “BINI.” The company stated the transition unifies its commercial Class 1, 3 and 4 vehicles under a single…
-
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence and genomic data to accelerate oncology drug discovery, announced the appointment of Lee T. Schalop, MD, to its Board of Directors. Dr. Schalop, co-founder and former CEO of Oncoceutics Inc., brings over 20 years of experience in biotechnology leadership and financial markets, with a…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB): Innovation Meets Science Through Scalable Platform
Nutriband (NASDAQ: NTRB) is positioning at the forefront of abuse-deterrent drug delivery in advancing its flagship fentanyl patch and buprenorphine candidates. The company combines transdermal innovation with abuse-deterrent science to meet critical public health needs. According to Nurtiband, AVERSA Fentanyl, with the possibility to reach peak annual U.S. sales of $80 to $200 million, holds…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Builds Momentum to Bring New Hope to Neuro Patients
Clene (NASDAQ: CLNN), together with its subsidiary Clene Nanomedicine Inc., is preparing to initiate neurofilament biomarker analyses for its lead drug candidate CNM-Au8(R) in ALS, following feedback from the FDA during a recent Type C meeting. Slated for early Q4 2025, the analyses will assess changes in neurofilament light chain (“NfL”)—a recognized marker for neurodegeneration—among…
-
MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Tees Up Innovation for the ‘Sport’s New Face’
Newton Golf Company (NASDAQ: NWTG) is delivering innovative products to the dynamic market as a surge in women’s golf participation is reshaping the industry. The company recently released a lighter shaft option, designed to deliver premium performance for golfers of all levels, from weekend enthusiasts to tour professionals. “Newton Golf’s introduction of its lighter shaft further…
-
MissionIRNewsBreaks – BluSky AI Inc. (OTC: BSAI) CEO Featured on IBN’s GotStocks Podcast to Discuss Scalable AI Infrastructure Strategy
BluSky AI (OTC: BSAI) CEO Trent D’Ambrosio was featured on the latest episode of IBN’s GotStocks Podcast, where he outlined the company’s mission to deliver modular, high-performance AI infrastructure with dramatically shortened build times. D’Ambrosio highlighted BluSky’s focus on inference computing and its scalable, adaptive design approach, capable of delivering facilities in 12 to 18…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Reports Strong Expectations for Quantum Computing-Based Optimization
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, released findings from a survey conducted with Wakefield Research showing rising enterprise interest in quantum optimization. The survey polled 400 business leaders, defined as logistics or operational managers and decision-makers who make decisions about optimization in their line-of-business. Of the business…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2025 Innovation Award for Remote Cardiac Diagnostics
HeartBeam (NASDAQ: BEAT), a medical technology company advancing personalized cardiac care, has received the Innovation Award in Remote Cardiac Diagnostics from the 2025 Medical Device Network Excellence Awards. The honor recognizes HeartBeam’s FDA-cleared 3D ECG technology, which enables clinical-grade arrhythmia diagnostics in non-clinical settings via a compact, cable-free device. The synthesized 12-lead ECG software is…
-
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Secures EU Patent for AI-Designed Cancer Drug LP-284
Lantern Pharma (NASDAQ: LTRN) announced the European Patent Office has issued a notice of allowance for a composition of matter patent covering LP-284, a clinical-stage drug candidate for relapsed or refractory non-Hodgkin’s lymphoma. The patent, expected to grant with exclusivity through 2039, adds to existing IP in the U.S. and Japan and supports global commercialization…
-
MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Integrates AI Object Detection with U.S. Army Recon Drones
Safe Pro Group (NASDAQ: SPAI) has integrated its patented AI object detection models into drone platforms selected for the U.S. Army’s Short Range Reconnaissance Program of Record, aiming to enhance explosive threat detection and ISR capabilities. The technology, battle-tested in Ukraine, enables rapid identification of over 150 threat types and is scalable across real-time and…
-
MissionIRNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Leveraging Crypto to Bridge New World and Classic Industry
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S. The company recently announced plans to begin holding bitcoin as part of its treasury reserves, marking SolarBank…
-
MissionIRNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Charts Dual-Path for NRX-100
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, is accelerating its push toward regulatory approval of NRX-100, a preservative-free intravenous ketamine formulation. “The company recently filed an application under the newly created FDA Commissioner’s National Priority Voucher (‘CNPV’) program, which promises significantly shortened review timelines for drugs…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Sets Key Dates for 25% Preferred Stock Dividend
Nutriband (NASDAQ: NTRB) is reminding shareholders of its upcoming 25% preferred stock dividend. Shareholders of record as of July 25, 2025, will receive one preferred share for every four common shares held, with the dividend payable on August 5. Each preferred share will be convertible to one common share upon FDA approval of Nutriband’s AVERSA…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharma company focused on treating brain and CNS cancers, will implement a 1-for-12 reverse stock split effective July 22, 2025. Its common stock will continue trading under the symbol CNSP but with a new CUSIP number: 18978H508. Each 12 shares of common stock will convert into one, with proportional adjustments…
-
MissionIRNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, is executing a dual growth strategy focused on expanding its national network of mental health clinics through its subsidiary, HOPE Therapeutics, and advancing its proprietary NMDA-based therapies toward FDA approval. HOPE recently announced plans to deploy $10.3 million in total acquisition capital to purchase clinics that provide…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Highlights August as Key Window for Commercial EV Incentives Through Bollinger Motors
Mullen Automotive (NASDAQ: MULN), through its subsidiary Bollinger Motors, announced that August will present a prime opportunity to purchase commercial EVs as New York’s Truck Voucher Incentive Program (NYTVIP) is set to be replenished. The program offers up to $144,000 in point-of-sale vouchers, which, when combined with the federal 45W tax credit of up to…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Advancing Louisiana SMC to Play Pivotal Role in Critical Mineral Supply Chain
- MissionIRNewsBreaks – A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Reports Q3 2025 Results and Advances Yochananof Smart Cart Deployment
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Releases New Datavault Insights Highlighting Execution, Growth and Global Momentum
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Sets Nov. 17 Release for Q3 2025 Financial Highlights
- Federal Permits to Advance Ambler Access Project Strengthen Alaska’s Role in Domestic Supply Chain of Critical Minerals